1. Ku C.S., Polychronakos C., Tan E.K., et al. A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. 2012: ePub ahead of print.

  2. Lee J.H., Huynh M., Silhavy J.L., et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. 2012: Nat. Genet. 44(8): 941-945.

  3. 3. Sheppard K., Kinross K.M., Solomon B., et al. Targeting PI3 kinase/AKT/mTOR signaling in cancer. 2012: Crit. Rev. Oncogenesis 1 (1):69-95.

Riviere JB, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, Conway RL et al. (2012) De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nature genetics 44 (8):934-940. doi:10.1038/ng.2331